Shares of biotechnology company Inhibitex Inc. sank in Tuesday afternoon trading, a day after the company said its potential shingles treatment did not yield statistically significant differences when compared to another drug in a midstage clinical trial.
All News, Video and Posts related to SECTOR: Health Care
Popular Posts:
- Man dies feet from ER after hospital says to call 911
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks